Middle East & Africa PCR Technologies Market Forecast to 2030 - Regional Analysis - by Technology, Offerings, Application, and End User

List of Tables

The Middle East & Africa PCR technologies market is expected to grow from US$ 626.35 million in 2022 to US$ 1,057.27 million by 2030. It is estimated to record a CAGR of 6.8% from 2022 to 2030.

Rising Prevalence of Genetic and Infectious Diseases Bolsters Middle East & Africa PCR Technologies Market

According to the National Organization's information on genetic conditions or congenital disabilities, genetic disorders are rare conditions, but they collectively comprise over 15,500 positive diagnoses every year. Estimates published in a report by MJH Life Sciences (US) in 2022 state that ~300,000 newborns are born with sickle cell disease (SCD) globally every year, accounting for ~5% of the global population. Further, as per the June 2020 report by Novartis AG, SCD affects around eight million individuals globally. Around 500 children die from SCD-related complications per day in Africa, where the disease has the highest burden. As a result of the rising incidence of SCDs, the adoption of digital polymerase chain reaction (dPCR) is increasing in pathology centers, wherein this technology is being exploited for targeting various DNA-specific sequences to confirm diagnoses and design various clinical tests. dPCR can target specific DNA sequences in just one molecule of DNA. This tool allows researchers to detect rare genetic mutations that are difficult to identify by using real-time PCR. The COVID-19 outbreak had a significant impact on the PCR technologies market. PCR is a nearly ubiquitous, robust, and reliable technology used in most molecular biology labs to amplify specific stretches of DNA for genotyping, cloning, and analysis of single nucleotide variations. The amplified DNA even serves as the basis for most next-generation sequencing (NGS) preparation. Nearly all diagnostic tests used real-time PCR for testing people having symptoms of COVID-19. Most of the biotech and pharmaceutical businesses shifted their focus toward research and development (R&D) divisions to find novel compounds or therapeutic approaches for COVID-19, which, in turn, benefitted the PCR technologies market. In February 2022, Roche added the Cobas 5800 System, a newly released molecular laboratory instrument, to its COVID-19 PCR portfolio for use in nations that accept the CE certification. These products include the Cobas SARS-CoV-2 and influenza A/B tests, as well as the Cobas SARS-CoV-2 qualitative test. The product offers uniform performance and efficiency in low-, medium-, and high-volume molecular laboratory tests. Thus, the increasing incidence of genetic and infectious diseases supports the growth of the PCR technologies market.

Middle East & Africa PCR Technologies Market Overview

The Middle East & Africa PCR technologies market is segmented into Saudi Arabia, the UAE, South Africa, and the Rest of the Middle East & Africa. The region is expected to experience significant growth due to an increase in the development of varied reagent systems and automated systems in this region, a wide range of new products in diagnostic laboratories, and a growing number of conferences, meetings, workshops, and symposiums. Saudi Arabia is among the fastest-growing countries in the Middle East & Africa. Changing healthcare infrastructure through public-private partnerships between government and international players strengthens the country's healthcare sector. These partnerships and privatization efforts align with the Saudi government's "Vision 2030" policies to transform the national economy. As per the International Trade Administration, the Saudi Arabian government invested ~US$ 65 billion to build the country's healthcare infrastructure as part of Vision 2030. Increased investment in infrastructure and innovation is anticipated to favor the market positively. PCR technologies have wide applications in the diagnosis of infectious diseases, oncology, autoimmune diseases, genetic diseases, HIV/AIDS, and others. It is used by medical practitioners in hospitals, laboratories, and other healthcare facilities and at various stages of the patient treatment process. Further, studies on DNA polymorphism, lung cancer, and colorectal cancer use dPCR and qPCR techniques to assess the mRNA expression of genes, boosting the PCR technologies market. Saudi Arabia has a growing number of genetic diseases due to consanguineous marriage, and thus, the increase in premarital genetic screening drives the market growth. The Government of Saudi Arabia has made it mandatory to undergo premarital genetic screening before marriage to check genetic compatibility to reduce hereditary blood diseases such as sickle cell and beta-thalassemia, which are most prevalent in the country. Therefore, the rising prevalence of genetic diseases and increasing premarital genetic testing in Saudi Arabia drive the market growth. Also, the growing number of cancer cases has fueled cancer research in Saudi Arabia. As per Globocan 2020 data, the country recorded ~27,885 new cancer cases. The five-year prevalence rate for cancer in all ages was found to be 237.4 per 100,000 people, which, in turn, propels the demand for PCR technologies in Saudi Arabia.

Middle East & Africa PCR Technologies Market Revenue and Forecast to 2030 (US$ Million)

Middle East & Africa PCR Technologies Market Segmentation

The Middle East & Africa PCR technologies market is segmented into technology, offerings, application, end user, and country.

Based on technology, the Middle East & Africa PCR technologies market is segmented into real time PCR, conventional PCR, reverse transcription, digital PCR, multiplex RTPCR, hot start PCR, and others. The real time PCR segment held the largest share of Middle East & Africa PCR technologies market in 2022.

In terms of offerings, the Middle East & Africa PCR technologies market is segmented into reagents & consumables, instruments, and software & services. The reagents & consumables segment held the largest share of Middle East & Africa PCR technologies market in 2022. Further, reagents & consumables segment are categorized into reagents, vials size, and other consumables. Furthermore, vials size is segmented into 0.2ml to 2ml, 0.1 ml to 0.3 ml, 2 ml to 5ml, and other vials. Additionally, instruments segment is bifurcated into benchtop PCR, and portable thermocyclers/PCR.

Based on application, the Middle East & Africa PCR technologies market is segmented into gene expression analysis, genetic sequencing, genotyping, nucleic acid synthesis, standard validation, point of care diagnostic application, environmental application, and others. The gene expression analysis segment held the largest share of Middle East & Africa PCR technologies market in 2022.

Based on end user, the Middle East & Africa PCR technologies market is segmented into hospitals & diagnostic centres, pharmaceutical & biotechnology companies, academic institutes & research laboratories, and others. The hospitals & diagnostic centres segment held the largest share of Middle East & Africa PCR technologies market in 2022.

By country, the Middle East & Africa PCR technologies market has been categorized into Saudi Arabia, South Africa, the UAE, and the Rest of Middle East & Africa. Saudi Arabia dominated the Middle East & Africa PCR technologies market in 2022.

Thermo Fisher Scientific Inc, Promega Corp, QIAGEN NV, bioMerieux SA, Hoffmann-La Roche Ltd, Bio-Rad Laboratories Inc, Becton Dickinson and Co, Takara Bio Inc, Standard Bio Tools Inc, and Ellume Ltd are some of the leading companies operating in the Middle East & Africa PCR technologies market.

Product Code: BMIRE00030470

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Middle East & Africa PCR Technologies Market - Key Industry Dynamics

4.1 PCR Technologies Market - Key Industry Dynamics
4.2 Market Drivers
- 4.2.1 Rising Prevalence of Genetic and Infectious Diseases
4.3 Market Restraints
- 4.3.1 High Costs of PCR Systems and Availability of Alternative Assays
4.4 Market Opportunities
- 4.4.1 Increasing Adoption of PCR Techniques in Emerging Countries
- 4.4.2 Increasing Demand for POC Testing
4.5 Future Trends
- 4.5.1 Advancements in PCR Technologies
4.6 Impact of Drivers and Restraints:

5. PCR Technologies Market - Middle East & Africa Market Analysis

5.1 PCR Technologies Market Revenue (US$ Million), 2020 - 2030

6. Middle East & Africa PCR Technologies Market Analysis - By Technology

6.1 Overview
6.2 Real Time PCR
- 6.2.1 Overview
- 6.2.2 Real Time PCR Market, Revenue and Forecast to 2030 (US$ Million)
6.3 Conventional PCR
- 6.3.1 Overview
- 6.3.2 Conventional PCR Market, Revenue and Forecast to 2030 (US$ Million)
6.4 Reverse Transcription PCR
- 6.4.1 Overview
- 6.4.2 Reverse Transcription PCR Market, Revenue and Forecast to 2030 (US$ Million)
6.5 Digital PCR
- 6.5.1 Overview
- 6.5.2 Digital PCR Market, Revenue and Forecast to 2030 (US$ Million)
6.6 Multiplex RT PCR
- 6.6.1 Overview
- 6.6.2 Multiplex RT PCR Market, Revenue and Forecast to 2030 (US$ Million)
6.7 Hot Start PCR
- 6.7.1 Overview
- 6.7.2 Hot Start PCR Market, Revenue and Forecast to 2030 (US$ Million)
6.8 Others
- 6.8.1 Overview
- 6.8.2 Others Market, Revenue and Forecast to 2030 (US$ Million)

7. Middle East & Africa PCR Technologies Market Analysis - By Offerings

7.1 Overview
7.2 PCR Technologies Market Revenue Share, by Offerings 2022 & 2030 (%)
7.3 Reagents and Consumables
- 7.3.1 Overview
- 7.3.2 Reagents and Consumables Market, Revenue and Forecast to 2030 (US$ Million)
  - 7.3.2.1 PCR Technologies Market - Revenue and Forecast to 2030(US$ Million) - By Reagents and Consumables
    - 7.3.2.1.1 PCR Technologies Market - Revenue and Forecast to 2030(US$ Million) - By Vial Size
7.4 Instruments
- 7.4.1 Overview
- 7.4.2 Instruments Market, Revenue and Forecast to 2030 (US$ Million)
  - 7.4.2.1 PCR Technologies Market - Revenue and Forecast to 2030(US$ Million) - By Instruments
7.5 Software and Services
- 7.5.1 Overview
- 7.5.2 Software and Services Market, Revenue and Forecast to 2030 (US$ Million)

8. Middle East & Africa PCR Technologies Market Analysis - By Application

8.1 Overview
8.2 PCR Technologies Market Revenue Share, by Application 2022 & 2030 (%)
8.3 Gene Expression Analysis
- 8.3.1 Overview
- 8.3.2 Gene Expression Analysis Market, Revenue and Forecast to 2030 (US$ Million)
8.4 Genetic Sequencing
- 8.4.1 Overview
- 8.4.2 Genetic Sequencing Market, Revenue and Forecast to 2030 (US$ Million)
8.5 Genotyping
- 8.5.1 Overview
- 8.5.2 Genotyping Market, Revenue and Forecast to 2030 (US$ Million)
8.6 Nucleic Acid Synthesis
- 8.6.1 Overview
- 8.6.2 Nucleic Acid Synthesis Market, Revenue and Forecast to 2030 (US$ Million)
8.7 Standard Validation
- 8.7.1 Overview
- 8.7.2 Standard Validation Market, Revenue and Forecast to 2030 (US$ Million)
8.8 Point of Care Diagnostics
- 8.8.1 Overview
- 8.8.2 Point of Care Diagnostics Market, Revenue and Forecast to 2030 (US$ Million)
8.9 Environmental Application
- 8.9.1 Overview
- 8.9.2 Environmental Application Market, Revenue and Forecast to 2030 (US$ Million)
8.10 Others
- 8.10.1 Overview
- 8.10.2 Others Market, Revenue and Forecast to 2030 (US$ Million)

9. Middle East & Africa PCR Technologies Market Analysis - By End User

9.1 Overview
9.2 PCR Technologies Market Revenue Share, by End User 2022 & 2030 (%)
9.3 Hospitals and Diagnostic Centers
- 9.3.1 Overview
- 9.3.2 Hospitals and Diagnostic Centers Market, Revenue and Forecast to 2030 (US$ Million)
9.4 Academia and Research Institutes
- 9.4.1 Overview
- 9.4.2 Academia and Research Institutes Market, Revenue and Forecast to 2030 (US$ Million)
9.5 Pharmaceutical and Biotechnology Companies
- 9.5.1 Overview
- 9.5.2 Pharmaceutical and Biotechnology Companies Market, Revenue and Forecast to 2030 (US$ Million)
9.6 Others
- 9.6.1 Overview
- 9.6.2 Others Market, Revenue and Forecast to 2030 (US$ Million)

10. Middle East & Africa PCR Technologies Market -Country Analysis

10.1 Middle East & Africa: PCR Technologies Market
- 10.1.1 Overview
- 10.1.2 Middle East & Africa PCR Technologies Market Revenue and Forecast and Analysis - By Country
  - 10.1.2.1 Saudi Arabia
    - 10.1.2.1.1 Overview
  - 10.1.2.2 Saudi Arabia PCR Technologies Market Revenue and Forecast to 2030 (US$ Mn)
    - 10.1.2.2.1 Saudi Arabia PCR Technologies Market Breakdown by Technology
    - 10.1.2.2.2 Saudi Arabia PCR Technologies Market Breakdown by Offerings
    - 10.1.2.2.2.1 Saudi Arabia PCR Technologies Market Breakdown by Instruments
    - 10.1.2.2.2.2 Saudi Arabia PCR Technologies Market Breakdown by Reagents and Consumables
    - 10.1.2.2.2.2.1 Saudi Arabia PCR Technologies Market Breakdown by Vial Size
    - 10.1.2.2.3 Saudi Arabia PCR Technologies Market Breakdown by Application
    - 10.1.2.2.4 Saudi Arabia PCR Technologies Market Breakdown by End User
  - 10.1.2.3 South Africa
    - 10.1.2.3.1 Overview
  - 10.1.2.4 South Africa PCR Technologies Market Revenue and Forecast to 2030 (US$ Mn)
    - 10.1.2.4.1 South Africa PCR Technologies Market Breakdown by Technology
    - 10.1.2.4.2 South Africa PCR Technologies Market Breakdown by Offerings
    - 10.1.2.4.2.1 South Africa PCR Technologies Market Breakdown by Instruments
    - 10.1.2.4.2.2 South Africa PCR Technologies Market Breakdown by Reagents and Consumables
    - 10.1.2.4.2.2.1 South Africa PCR Technologies Market Breakdown by Vial Size
    - 10.1.2.4.3 South Africa PCR Technologies Market Breakdown by Application
    - 10.1.2.4.4 South Africa PCR Technologies Market Breakdown by End User
  - 10.1.2.5 United Arab Emirates
    - 10.1.2.5.1 Overview
  - 10.1.2.6 United Arab
    - 10.1.2.6.1 United Arab Emirates PCR Technologies Market Breakdown by Technology
    - 10.1.2.6.2 United Arab Emirates PCR Technologies Market Breakdown by Offerings
    - 10.1.2.6.2.1 United Arab Emirates PCR Technologies Market Breakdown by Instruments
    - 10.1.2.6.2.2 United Arab Emirates PCR Technologies Market Breakdown by Reagents and Consumables
    - 10.1.2.6.2.2.1 United Arab Emirates PCR Technologies Market Breakdown by Vial Size
    - 10.1.2.6.3 United Arab Emirates PCR Technologies Market Breakdown by Application
    - 10.1.2.6.4 United Arab Emirates PCR Technologies Market Breakdown by End User
  - 10.1.2.7 Rest of Middle East & Africa
    - 10.1.2.7.1 Overview
  - 10.1.2.8 Rest of Middle East & Africa PCR Technologies Market Revenue and Forecast to 2030 (US$ Mn)
    - 10.1.2.8.1 Rest of Middle East & Africa PCR Technologies Market Breakdown by Technology
    - 10.1.2.8.2 Rest of Middle East & Africa PCR Technologies Market Breakdown by Offerings
    - 10.1.2.8.2.1 Rest of Middle East & Africa PCR Technologies Market Breakdown by Instruments
    - 10.1.2.8.2.2 Rest of Middle East & Africa PCR Technologies Market Breakdown by Reagents and Consumables
    - 10.1.2.8.2.2.1 Rest of Middle East & Africa PCR Technologies Market Breakdown by Vial Size
    - 10.1.2.8.3 Rest of Middle East & Africa PCR Technologies Market Breakdown by Application
    - 10.1.2.8.4 Rest of Middle East & Africa PCR Technologies Market Breakdown by End User

11. PCR Technologies Market-Industry Landscape

11.1 Overview
11.2 Growth Strategies in the PCR Technologies Market
11.3 Inorganic Growth Strategies
- 11.3.1 Overview
11.4 Organic Growth Strategies
- 11.4.1 Overview

12. Company Profiles

12.1 Thermo Fisher Scientific Inc
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 Promega Corp
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 QIAGEN NV
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 bioMerieux SA
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 Hoffmann-La Roche Ltd
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 Bio-Rad Laboratories Inc
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 Becton Dickinson and Co
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 Takara Bio Inc
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
12.9 Standard Biotools Inc
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments
12.10 Ellume Ltd
- 12.10.1 Key Facts
- 12.10.2 Business Description
- 12.10.3 Products and Services
- 12.10.4 Financial Overview
- 12.10.5 SWOT Analysis
- 12.10.6 Key Developments

13. Appendix

13.1 About the Insight Partners
13.2 Glossary of Terms